Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: In vitro and in vivo studies. Dong XD, Zhang M, Teng QX, Lei ZN, et al. Cancer Lett 2024;607:217309.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dong XD, Zhang M, Teng QX, Lei ZN, et al. Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: In vitro and in vivo studies. Cancer Lett 2024;607:217309.
PMID: 39481798